Toshiaki Takahashi Selected Research

Toshiaki Takahashi Research Topics

Disease

153	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 02/2007
116	Neoplasms (Cancer) 05/2024 - 05/2003
33	Lung Neoplasms (Lung Cancer) 06/2023 - 09/2004
28	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024 - 08/2007
28	Congenital Diaphragmatic Hernias 02/2021 - 08/2014
25	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2010
19	Disease Progression 12/2023 - 12/2002
15	Adenocarcinoma of Lung 02/2023 - 01/2011
14	Hypoxia (Hypoxemia) 01/2017 - 08/2010
12	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2021 - 08/2009
12	Adenocarcinoma 12/2020 - 02/2007
11	Neutropenia 12/2020 - 03/2014
9	Wounds and Injuries (Trauma) 08/2023 - 12/2006
8	Febrile Neutropenia 12/2023 - 01/2016
7	Diarrhea 11/2023 - 08/2009
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022 - 12/2009
7	Dysferlinopathy 01/2020 - 05/2005
7	Thymoma (Thymic Carcinoma) 01/2017 - 12/2009
7	Miyoshi myopathy 04/2013 - 12/2002
6	Cachexia 05/2024 - 11/2017
6	Carcinoma (Carcinomatosis) 01/2024 - 04/2010
6	Pneumonia (Pneumonitis) 04/2022 - 08/2016
6	Anorexia 07/2021 - 08/2009
6	Osteosarcoma (Osteogenic Sarcoma) 09/2004 - 10/2003
5	Nausea 11/2023 - 11/2010
5	Pain (Aches) 07/2023 - 10/2004
5	Malignant Mesothelioma 09/2019 - 03/2010
5	Thrombocytopenia (Thrombopenia) 01/2017 - 11/2009
4	Infections 04/2024 - 05/2014
4	Inflammation (Inflammations) 05/2023 - 09/2018
4	Muscular Dystrophies (Muscular Dystrophy) 01/2022 - 11/2004
4	Breast Neoplasms (Breast Cancer) 09/2018 - 03/2011
4	Vascular Remodeling 02/2018 - 05/2015
4	Pulmonary Hypertension 02/2017 - 01/2011
4	Muscular Diseases (Myopathy) 12/2015 - 12/2005
3	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 09/2011
3	Body Weight (Weight, Body) 05/2024 - 02/2021

Drug/Important Bio-Agent (IBA)

61	ErbB Receptors (EGF Receptor)IBA 12/2023 - 11/2008
33	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2008
29	PlatinumIBA 12/2023 - 08/2007
26	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 03/2009
26	nitrofenIBA 02/2021 - 08/2014
22	Biomarkers (Surrogate Marker)IBA 06/2023 - 02/2011
22	Gefitinib (Iressa)FDA Link 01/2023 - 02/2007
21	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2014 - 11/2009
17	osimertinibIBA 12/2023 - 01/2017
15	DysferlinIBA 01/2020 - 12/2002
14	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2016
14	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 02/2007
13	B7-H1 AntigenIBA 02/2023 - 12/2018
12	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2023 - 02/2007
12	Docetaxel (Taxotere)FDA Link 09/2019 - 02/2007
11	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 08/2010
11	Vinorelbine (Navelbine)FDA LinkGeneric 12/2023 - 03/2009
11	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 02/2014 - 08/2010
10	Pemetrexed (MTA)FDA Link 12/2023 - 03/2010
10	NivolumabIBA 01/2021 - 01/2016
9	Proteins (Proteins, Gene)FDA Link 11/2023 - 04/2009
9	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 06/2010
9	pembrolizumabIBA 01/2022 - 03/2019
8	HexokinaseIBA 02/2014 - 01/2011
7	Irinotecan (Camptosar)FDA LinkGeneric 01/2022 - 09/2004
7	Deoxyglucose (2 Deoxy D glucose)IBA 02/2014 - 08/2010
6	amrubicinIBA 12/2023 - 08/2007
6	durvalumabIBA 04/2022 - 10/2020
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 02/2007
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2014 - 05/2011
5	ParaffinIBA 04/2024 - 04/2014
5	Thymidylate SynthaseIBA 01/2014 - 09/2011
5	TOR Serine-Threonine KinasesIBA 10/2013 - 01/2011
4	EnzymesIBA 11/2023 - 08/2004
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 12/2009
4	Formaldehyde (Formol)FDA Link 01/2021 - 04/2014
4	Anaplastic Lymphoma KinaseIBA 10/2020 - 07/2015
4	Gemcitabine FDA Link 06/2019 - 10/2009
4	CrizotinibIBA 10/2018 - 09/2013
4	Bevacizumab (Avastin)FDA Link 11/2016 - 06/2013
4	Orotate PhosphoribosyltransferaseIBA 01/2014 - 09/2011
4	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 01/2014 - 09/2011
4	Hydroxyl RadicalIBA 09/2004 - 10/2003
4	Free RadicalsIBA 09/2004 - 10/2003
4	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 09/2004 - 10/2003
3	sotorasibIBA 11/2023 - 01/2021
3	LigandsIBA 01/2023 - 03/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
3	Therapeutic UsesIBA 01/2022 - 11/2011
3	130-nm albumin-bound paclitaxelIBA 01/2022 - 03/2019
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022 - 05/2004

Therapy/Procedure

82	Drug Therapy (Chemotherapy) 01/2024 - 02/2007
66	Therapeutics 01/2024 - 05/2005
32	Radiotherapy 04/2024 - 05/2003
20	Chemoradiotherapy 01/2022 - 12/2009
12	Adjuvant Chemotherapy 12/2023 - 03/2009
9	Aftercare (After-Treatment) 11/2021 - 05/2011
7	Catheters 04/2024 - 12/2015
5	Activities of Daily Living (ADL) 10/2023 - 03/2005
4	Appendectomy 12/2019 - 09/2010
4	Combination Drug Therapy (Combination Chemotherapy) 01/2019 - 01/2013
4	Cranial Irradiation 04/2018 - 01/2017
3	Immunotherapy 01/2022 - 01/2021